Entry Detail



General Information

Database ID:exR0089746
RNA Name:hsa-miR-320a-3p
RNA Type:miRNA
Chromosome:chr8
Starnd:-
Coordinate:
Start Site(bp):22244975End Site(bp):22244996
External Links:hsa-miR-320a-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACAP2
chr3
195274745
195443044
-
ASB1
chr2
238426742
238452250
+
BLCAP
chr20
37492472
37527931
-
BTAF1
chr10
91923770
92030325
+
CGN
chr1
151510510
151538692
+
CKAP5
chr11
46743048
46846308
-
CRTC3
chr15
90529923
90645345
+
FJX1
chr11
35618460
35620865
+
GMCL1
chr2
69829660
69881384
+
GNAI2
chr3
50226292
50259362
+
HECTD2
chr10
91409280
91514829
+
HSP90AB1
chr6
44246166
44253888
+
IGF2BP3
chr7
23310209
23470491
-
MKI67
chr10
128096659
128126423
-
NR4A2
chr2
156324437
156342348
-
PFN1
chr17
4945652
4949061
-
SGK1
chr6
134169246
134318112
-
SIN3A
chr15
75369379
75455842
-
SRSF7
chr2
38743599
38751494
-
TRIM14
chr9
98069275
98119222
-
VMA21
chrX
151396515
151409364
+
ZCCHC2
chr18
62523025
62587709
+
CDK2AP1
chr12
123250112
123272334
-
CTNNA1
chr5
138610967
138935034
+
HLA-DRA
chr6
32439878
32445046
+
MIF
chr22
23894383
23895227
+
PCLAF
chr15
64364304
64387687
-
SLC5A3
chr21
34073578
34106260
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002044.1
chr16
73014319
73014476
-
AC016876.2
chr17
7581964
7584086
-
AC092718.4
chr16
81030770
81031485
+
AL022311.1
chr22
37876148
37895563
+
AL162258.1
chr1
153626332
153634340
-
DLEU1
chr13
50082169
50906856
+
GAS5
chr1
173858559
173868882
-
LINC00641
chr14
21200079
21206900
-
MALAT1
chr11
65497688
65506516
+
MIR3142HG
chr5
160438594
160487426
+
NEAT1
chr11
65422774
65445540
+
NR2F2-AS1
chr15
96110040
96327361
-
OIP5-AS1
chr15
41283990
41309737
+
SNHG1
chr11
62851984
62855953
-
SNHG12
chr1
28578538
28583132
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.